Does A9531 require prior authorization?

No, A9531 does not require prior authorization (high confidence). Covered without prior authorization.

What is the Medicare reimbursement rate for A9531?

Medicare facility rate: N/A. Non-facility rate: N/A. Work RVU: 0.00.

HCPCS/CPT

No Prior Auth Required

Covered without prior authorization (high confidence)

Work RVU

0.00

Facility

N/A

Non-Facility

N/A

Indication: Strontium-89 is medically necessary for symptomatic bone metastases when both: (1) Confirmed osteoblastic bone metastases from solid organ cancer; (2) Pain not adequately controlled by conventional therapy.

CARELON-theranostics-therapeutic-radiopharmaceuticals-2026-04-04, Theranostics Therapeutic Radiopharmaceuticals

Ask Backwork about documentation requirements, denial risks, or coverage in your state.